Skip to main content
Top
Published in: Cardiovascular Toxicology 2/2018

01-04-2018

Asiatic Acid Ameliorates Doxorubicin-Induced Cardiac and Hepato-Renal Toxicities with Nrf2 Transcriptional Factor Activation in Rats

Authors: Sarika M. Kamble, Chandragouda R. Patil

Published in: Cardiovascular Toxicology | Issue 2/2018

Login to get access

Abstract

Asiatic acid (AA), a pentacyclic triterpenoid, is a key phytoconstituent of Centella asiatica. AA is a patented as a cytotoxic substance, and it exerts cytotoxicity against Hep3B, Hela and MCF-7 cell lines. However, pentacyclic triterpenoids also modulate the expression and transcriptional activities of Nrf2 and exert cytoprotective effects. In this study, we investigated the effects of AA on the doxorubicin (DXR)-induced organ toxicities and expression of the Nrf2. DXR toxicity was induced by a single intravenous injection of 65.75 mg/kg of DXR. Seven days pretreatment with AA at the doses of 5, 10 and 20 mg/kg, p.o. significantly reverted the DXR-induced oxidative stress in heart, liver and kidney. The biochemical indicators of DXR toxicity including increased activities of serum creatinine kinase isoenzyme, transaminases and lactate dehydrogenase along with increased serum creatinine and serum blood urea nitrogen were normalised by AA. AA was also protected against the DXR-induced histological alterations including necrosis, hyaline degeneration and congestion in the heart; leukocytic inflammation, centrilobular necrosis, apoptosis and fatty changes in the liver; and necrosis and inflammation in the kidney. The protective effects of AA were dose dependent, and the 20 mg/kg dose exerted protection against the DXR toxicity by increasing Nrf2 protein expression.
Literature
1.
go back to reference Blum, R. H., & Carter, S. K. (1974). A new drug with significant clinical activity. Annals of Internal Medicine, 80, 249–256.CrossRefPubMed Blum, R. H., & Carter, S. K. (1974). A new drug with significant clinical activity. Annals of Internal Medicine, 80, 249–256.CrossRefPubMed
2.
go back to reference Mohan, M., Kamble, S., Ghadi, P., & Kastrure, S. (2010). Protective effect of Solanum torvum on doxorubicin-induced nephrotoxicity in rats. Food and Chemical Toxicology, 48, 436–440.CrossRefPubMed Mohan, M., Kamble, S., Ghadi, P., & Kastrure, S. (2010). Protective effect of Solanum torvum on doxorubicin-induced nephrotoxicity in rats. Food and Chemical Toxicology, 48, 436–440.CrossRefPubMed
3.
go back to reference Aluise, C. D., Miriyal, S., Noel, T., Sultana, R., Jungsuwadee, P., Taylor, T. J., et al. (2011). 2-Mercaptoethane sulfonate prevents doxorubicin-induced plasma protein oxidation and TNF-α release: Implications for the reactive oxygen species-mediated mechanisms of chemobrain. Free Radical Biology and Medicine, 50, 1630–1638.CrossRefPubMed Aluise, C. D., Miriyal, S., Noel, T., Sultana, R., Jungsuwadee, P., Taylor, T. J., et al. (2011). 2-Mercaptoethane sulfonate prevents doxorubicin-induced plasma protein oxidation and TNF-α release: Implications for the reactive oxygen species-mediated mechanisms of chemobrain. Free Radical Biology and Medicine, 50, 1630–1638.CrossRefPubMed
4.
go back to reference Tacar, O., Sriamornsak, P., & Dass, C. R. (2012). Doxorubicin: An update on anticancer molecular action, toxicity and novel drug delivery systems. Journal of Pharmacy and Pharmacology, 65, 157–170.CrossRefPubMed Tacar, O., Sriamornsak, P., & Dass, C. R. (2012). Doxorubicin: An update on anticancer molecular action, toxicity and novel drug delivery systems. Journal of Pharmacy and Pharmacology, 65, 157–170.CrossRefPubMed
5.
go back to reference Cecen, E., Dost, T., Culhac, N., Karul, A., Ergur, B., & Birincioglu, M. (2011). Protective effect of sylimerin on doxorubicin-induced toxicity. Asian Pacific Journal of Cancer Prevention, 12, 2697–2704.PubMed Cecen, E., Dost, T., Culhac, N., Karul, A., Ergur, B., & Birincioglu, M. (2011). Protective effect of sylimerin on doxorubicin-induced toxicity. Asian Pacific Journal of Cancer Prevention, 12, 2697–2704.PubMed
6.
go back to reference Zordoky, B. M., Anwar-Mohamed, A., Aboutabl, M. E., & Ayman, O. S. (2011). Acute doxorubicin toxicity differentially alters cytochrome P450 expression and arachidonic acid metabolism in rat kidney and liver. Drug Metabolism and Disposition, 39, 1140–1150.CrossRef Zordoky, B. M., Anwar-Mohamed, A., Aboutabl, M. E., & Ayman, O. S. (2011). Acute doxorubicin toxicity differentially alters cytochrome P450 expression and arachidonic acid metabolism in rat kidney and liver. Drug Metabolism and Disposition, 39, 1140–1150.CrossRef
7.
go back to reference Saad, S. Y., Najjar, T. A., & Al-Rykaby, A. C. (2001). The preventive role of deferoxamine against acute doxorubicin-s induced kidney, renal and hepatotoxicity in rats. Pharmacological Research, 43, 211–218.CrossRefPubMed Saad, S. Y., Najjar, T. A., & Al-Rykaby, A. C. (2001). The preventive role of deferoxamine against acute doxorubicin-s induced kidney, renal and hepatotoxicity in rats. Pharmacological Research, 43, 211–218.CrossRefPubMed
8.
go back to reference Li, S., Wang, W., Niu, T., Wang, H., Li, B., Shao, L., et al. (2014). Nrf2 deficiency exaggerates doxorubicin-induced cardiotoxicity and cardiac dysfunction. Oxidative Medicine and Cellular Longevity, 2014, 1–15. Li, S., Wang, W., Niu, T., Wang, H., Li, B., Shao, L., et al. (2014). Nrf2 deficiency exaggerates doxorubicin-induced cardiotoxicity and cardiac dysfunction. Oxidative Medicine and Cellular Longevity, 2014, 1–15.
9.
go back to reference European Patent. (2009). Anti-glycation properties of Asiatic acid and Madecassic acid. Bayer consumer care Ag and Caroline Segond. Patent No WO2001213 A1. European Patent. (2009). Anti-glycation properties of Asiatic acid and Madecassic acid. Bayer consumer care Ag and Caroline Segond. Patent No WO2001213 A1.
10.
go back to reference US Patent. (2004). Use of asiatic acid and asiaticoside for treatment of cancer. Oh et al and Wolf greenfield Sacks PC, Boston. Patent No US 2004/0097463 A1. US Patent. (2004). Use of asiatic acid and asiaticoside for treatment of cancer. Oh et al and Wolf greenfield Sacks PC, Boston. Patent No US 2004/0097463 A1.
11.
go back to reference Matsuda, H., Morikawa, T., Ueda, H., & Yoshikawa, M. (2001). Medicinal foodstuffs. XXVII. (1) Saponin constituents of gotu kola (2): Structures of new ursane-and oleanane-type triterpene oligoglycosides, centellasaponins B, C, and D, from Centella asiatica cultivated in Sri Lanka. Chemical and Pharmaceutical Bulletin, 49, 1368–1371.CrossRefPubMed Matsuda, H., Morikawa, T., Ueda, H., & Yoshikawa, M. (2001). Medicinal foodstuffs. XXVII. (1) Saponin constituents of gotu kola (2): Structures of new ursane-and oleanane-type triterpene oligoglycosides, centellasaponins B, C, and D, from Centella asiatica cultivated in Sri Lanka. Chemical and Pharmaceutical Bulletin, 49, 1368–1371.CrossRefPubMed
12.
go back to reference Wongekalak, L., Sakulsom, P., Jirasripongpun, K., & Hongsprabhas, P. (2011). Potential use of antioxidative mungbean protein hydrolysate as an anticancer Asiatic acid carrier. Food Research International, 44, 812–817.CrossRef Wongekalak, L., Sakulsom, P., Jirasripongpun, K., & Hongsprabhas, P. (2011). Potential use of antioxidative mungbean protein hydrolysate as an anticancer Asiatic acid carrier. Food Research International, 44, 812–817.CrossRef
13.
go back to reference Ramachandran, V., & Saravanan, R. (2013). Asiatic acid prevents lipid peroxidation and improves antioxidant status in rats with streptozotocin-induced diabetes. Journal of Functional Foods, 5, 1077–1087.CrossRef Ramachandran, V., & Saravanan, R. (2013). Asiatic acid prevents lipid peroxidation and improves antioxidant status in rats with streptozotocin-induced diabetes. Journal of Functional Foods, 5, 1077–1087.CrossRef
14.
go back to reference Yun, K., Kim, J., Lee, K., Jeong, S., Park, H., Jung, H., et al. (2008). Inhibition of LPS-induced NO and PGE2 production by asiatic acid via NF-κB inactivation in RAW 264.7 macrophages: Possible involvement of the IKK and MAPK pathways. International Immunopharmacology, 8, 431–441.CrossRefPubMed Yun, K., Kim, J., Lee, K., Jeong, S., Park, H., Jung, H., et al. (2008). Inhibition of LPS-induced NO and PGE2 production by asiatic acid via NF-κB inactivation in RAW 264.7 macrophages: Possible involvement of the IKK and MAPK pathways. International Immunopharmacology, 8, 431–441.CrossRefPubMed
15.
go back to reference Gao, J., Chen, J., Tang, X., Pan, L., Fang, F., Xu, L., et al. (2006). Mechanism underlying mitochondrial protection of Asiatic acid against hepatotoxicity in mice. Journal of Pharmacy and Pharmacology, 58, 227–233.CrossRefPubMed Gao, J., Chen, J., Tang, X., Pan, L., Fang, F., Xu, L., et al. (2006). Mechanism underlying mitochondrial protection of Asiatic acid against hepatotoxicity in mice. Journal of Pharmacy and Pharmacology, 58, 227–233.CrossRefPubMed
16.
go back to reference Krishnamurthy, R. G., Senut, M., Zemke, D., Min, J., Frenkel, M. B., Greenberg, E. J., et al. (2009). Asiatic acid, a pentacyclic triterpene from Centella asiatica, is neuroprotective in a mouse model of focal cerebral ischemia. Journal of Neuroscience Research, 87, 2541–2550.CrossRefPubMedPubMedCentral Krishnamurthy, R. G., Senut, M., Zemke, D., Min, J., Frenkel, M. B., Greenberg, E. J., et al. (2009). Asiatic acid, a pentacyclic triterpene from Centella asiatica, is neuroprotective in a mouse model of focal cerebral ischemia. Journal of Neuroscience Research, 87, 2541–2550.CrossRefPubMedPubMedCentral
17.
go back to reference Li, R., Lan, H. Y., & Chung, A. K. (2013). Distinct roles of Smads and microRNAs in TGF-b signaling during kidney diseases. Hong Kong Journal of Nephrology, 15, 14–21.CrossRef Li, R., Lan, H. Y., & Chung, A. K. (2013). Distinct roles of Smads and microRNAs in TGF-b signaling during kidney diseases. Hong Kong Journal of Nephrology, 15, 14–21.CrossRef
18.
go back to reference Lee, M. K., Kim, S. H., Yang, H., Lim, D. Y., Ryu, J. H., Lee, E. S., et al. (2009). Asiatic acid protect primary cell cultures of rat hepatocyte against carbon tetrachloride-induced injury via the cellular antioxidant system. Natural Product Communication, 4, 765–768. Lee, M. K., Kim, S. H., Yang, H., Lim, D. Y., Ryu, J. H., Lee, E. S., et al. (2009). Asiatic acid protect primary cell cultures of rat hepatocyte against carbon tetrachloride-induced injury via the cellular antioxidant system. Natural Product Communication, 4, 765–768.
19.
go back to reference Resende, F. A., de Andrade, C. A., da Silva, M. C., Kato, F. H., Cunha, W. R., & Tavares, D. C. (2006). Antimutagenicity of ursolic acid and oleanolic acid against doxorubicin-induced clastogenesis in Balb/c mice. Life Sciences, 79, 1268–1273.CrossRef Resende, F. A., de Andrade, C. A., da Silva, M. C., Kato, F. H., Cunha, W. R., & Tavares, D. C. (2006). Antimutagenicity of ursolic acid and oleanolic acid against doxorubicin-induced clastogenesis in Balb/c mice. Life Sciences, 79, 1268–1273.CrossRef
20.
go back to reference Cipak, L., Grausova, L., Miadokova, E., Novotny, L., & Rauko, P. (2006). Dual activity of triterpenoids: Apoptotic versus antidifferentiation effects. Archives of Toxicology, 80, 429–435.CrossRefPubMed Cipak, L., Grausova, L., Miadokova, E., Novotny, L., & Rauko, P. (2006). Dual activity of triterpenoids: Apoptotic versus antidifferentiation effects. Archives of Toxicology, 80, 429–435.CrossRefPubMed
21.
go back to reference Ryu, K., Susa, M., Choy, E., Yang, C., Hornicek, F. J., Mankin, H. J., et al. (2010). Oleanan triterpenoid CDDO-me induced apoptosis in multidrug resistance osteosarcoma cells through inhibition of stat 3 pathway. BMC Cancer, 10, 1–7.CrossRef Ryu, K., Susa, M., Choy, E., Yang, C., Hornicek, F. J., Mankin, H. J., et al. (2010). Oleanan triterpenoid CDDO-me induced apoptosis in multidrug resistance osteosarcoma cells through inhibition of stat 3 pathway. BMC Cancer, 10, 1–7.CrossRef
22.
go back to reference Kamble, S., Goyal, S., & Patil, C. (2014). Multifunctional pentacyclic triterpenoids as adjuvants in cancer chemotherapy: A review. RSC Advances, 4, 33370–33382.CrossRef Kamble, S., Goyal, S., & Patil, C. (2014). Multifunctional pentacyclic triterpenoids as adjuvants in cancer chemotherapy: A review. RSC Advances, 4, 33370–33382.CrossRef
23.
go back to reference Smirnova, N. A., Haskew-Layton, R. E., Basso, M., Hushpulian, D. M., Payappilly, J. B., Speer, R. E., et al. (2011). Development of Neh2-luciferase reporter and its application for high throughput screening and real-time monitoring of Nrf2 activators. Chemistry and Biology, 18, 752–765.CrossRefPubMedPubMedCentral Smirnova, N. A., Haskew-Layton, R. E., Basso, M., Hushpulian, D. M., Payappilly, J. B., Speer, R. E., et al. (2011). Development of Neh2-luciferase reporter and its application for high throughput screening and real-time monitoring of Nrf2 activators. Chemistry and Biology, 18, 752–765.CrossRefPubMedPubMedCentral
24.
go back to reference Wakabayashi, N., Dinkova-Kostova, A. T., Holtzclaw, W. D., Kang, M., Kobayashi, A., Yamamoto, M., et al. (2005). Extremely potent triterpenoid inducers of the phase 2 response: Correlations of protection against oxidant and inflammatory stress. Proceedings of the National Academy of Sciences of the United States of America, 101, 2040–2045.CrossRef Wakabayashi, N., Dinkova-Kostova, A. T., Holtzclaw, W. D., Kang, M., Kobayashi, A., Yamamoto, M., et al. (2005). Extremely potent triterpenoid inducers of the phase 2 response: Correlations of protection against oxidant and inflammatory stress. Proceedings of the National Academy of Sciences of the United States of America, 101, 2040–2045.CrossRef
25.
go back to reference Danesi, R., Tacca, M. D., & Soldan, G. (1986). Measurement of the SαT segment as the most reliable electrocardiogram parameter for the assessment of adriamycin-induced cardiotoxicity in the rat. Journal of Pharmaceutical Methods, 16, 251–259.CrossRef Danesi, R., Tacca, M. D., & Soldan, G. (1986). Measurement of the SαT segment as the most reliable electrocardiogram parameter for the assessment of adriamycin-induced cardiotoxicity in the rat. Journal of Pharmaceutical Methods, 16, 251–259.CrossRef
26.
go back to reference Atessahin, A., Yilmaz, S., Karahan, I., Ceribasi, A. O., & Karaoglu, A. (2005). Effects of lycopene against cisplatin-induced nephrotoxicity and oxidative stress in rats. Toxicology, 212, 116–123.CrossRefPubMed Atessahin, A., Yilmaz, S., Karahan, I., Ceribasi, A. O., & Karaoglu, A. (2005). Effects of lycopene against cisplatin-induced nephrotoxicity and oxidative stress in rats. Toxicology, 212, 116–123.CrossRefPubMed
27.
go back to reference Kono, Y. (1978). Generation of superoxide radical during autoxidation of hydroxylamine and an assay for superoxide dismutase. Archives of Biochemistry and Biophysics, 186, 189–195.CrossRefPubMed Kono, Y. (1978). Generation of superoxide radical during autoxidation of hydroxylamine and an assay for superoxide dismutase. Archives of Biochemistry and Biophysics, 186, 189–195.CrossRefPubMed
28.
go back to reference Ohkawa, H., Ohishi, N., & Yagi, K. (1979). Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Analytical Biochemistry, 95, 351–358.CrossRefPubMed Ohkawa, H., Ohishi, N., & Yagi, K. (1979). Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Analytical Biochemistry, 95, 351–358.CrossRefPubMed
29.
go back to reference Ellman, G. L. (1959). Tissue sulfhydril groups. Archives of Biochemistry and Biophysics, 82, 70–77.CrossRefPubMed Ellman, G. L. (1959). Tissue sulfhydril groups. Archives of Biochemistry and Biophysics, 82, 70–77.CrossRefPubMed
30.
go back to reference Kavitha, K., Thiyagarajan, P., Rathna, J., Mishra, R., & Nagini, S. (2013). Chemopreventive effects of diverse dietary phytochemicals against DMBA-induced hamster buccal pouch carcinogenesis via the induction of Nrf2-mediated cytoprotective antioxidant, detoxification, and DNA repair enzymes. Biochimie, 95, 1629–1639.CrossRefPubMed Kavitha, K., Thiyagarajan, P., Rathna, J., Mishra, R., & Nagini, S. (2013). Chemopreventive effects of diverse dietary phytochemicals against DMBA-induced hamster buccal pouch carcinogenesis via the induction of Nrf2-mediated cytoprotective antioxidant, detoxification, and DNA repair enzymes. Biochimie, 95, 1629–1639.CrossRefPubMed
31.
go back to reference Tran, K., Risinsong, R., Royce, D., Williams, C. R., Sporn, M. B., & Liby, K. (2012). The synthetic triterpenoid CDDO-methyl ester delays estrogen receptor-negative mammary carcinogenesis in polyoma middle T mice. Cancer Prevention Research, 5, 726–734.CrossRefPubMed Tran, K., Risinsong, R., Royce, D., Williams, C. R., Sporn, M. B., & Liby, K. (2012). The synthetic triterpenoid CDDO-methyl ester delays estrogen receptor-negative mammary carcinogenesis in polyoma middle T mice. Cancer Prevention Research, 5, 726–734.CrossRefPubMed
32.
go back to reference Babu, T. D., Kuttan, G., & Padikkala, J. (1995). Cytotoxic and anti-tumour properties of certain taxa of Umbelliferae with special reference to Centella asiatica (L.) Urban. Journal of Ethnopharmacology, 48, 53–57.CrossRefPubMed Babu, T. D., Kuttan, G., & Padikkala, J. (1995). Cytotoxic and anti-tumour properties of certain taxa of Umbelliferae with special reference to Centella asiatica (L.) Urban. Journal of Ethnopharmacology, 48, 53–57.CrossRefPubMed
33.
go back to reference Tallaj, J. A., Veronica, F., Rayburn, B. K., Pinderski, L., Benza, R. L., Pamboukian, S., et al. (2005). Response of doxorubicin-induced cardiomyopathy to the current management strategy of heart failure. The Journal of Heart and Lung Transplantation, 24, 2196–2200.CrossRefPubMed Tallaj, J. A., Veronica, F., Rayburn, B. K., Pinderski, L., Benza, R. L., Pamboukian, S., et al. (2005). Response of doxorubicin-induced cardiomyopathy to the current management strategy of heart failure. The Journal of Heart and Lung Transplantation, 24, 2196–2200.CrossRefPubMed
34.
go back to reference Bachur, N. R., Gordon, S. L., Gee, M. V., & Kon, H. (1979). NADPH cytochrome P-450 reductase activation of quinone anticancer agents to free radicals. Proceedings of the National Academy of Sciences of the United States of America, USA, 76, 954–957.CrossRefPubMedPubMedCentral Bachur, N. R., Gordon, S. L., Gee, M. V., & Kon, H. (1979). NADPH cytochrome P-450 reductase activation of quinone anticancer agents to free radicals. Proceedings of the National Academy of Sciences of the United States of America, USA, 76, 954–957.CrossRefPubMedPubMedCentral
35.
go back to reference Keizer, H. G., Pinedo, H. M., Schuurhuis, G. J., & Joenje, H. (1990). Doxorubicin (adriamycin): A critical review of free radical-dependent mechanisms of cytotoxicity. Pharmacology and Therapeutics, 47, 219–231.CrossRefPubMed Keizer, H. G., Pinedo, H. M., Schuurhuis, G. J., & Joenje, H. (1990). Doxorubicin (adriamycin): A critical review of free radical-dependent mechanisms of cytotoxicity. Pharmacology and Therapeutics, 47, 219–231.CrossRefPubMed
36.
go back to reference Lee, V., Randhawa, A. K., & Singhal, P. K. (1991). Adriamycin induced myocardial dysfunction in vitro is mediated by free radicals. American Journal of Physiology, 261, 989–995. Lee, V., Randhawa, A. K., & Singhal, P. K. (1991). Adriamycin induced myocardial dysfunction in vitro is mediated by free radicals. American Journal of Physiology, 261, 989–995.
37.
go back to reference Kamble, S., Mohan, M., & Kasture, S. (2009). Protective effect of Solanum torvum on doxorubicin-induced cardiactoxicity in rats. Pharmacologyonline, 2, 1192–1204. Kamble, S., Mohan, M., & Kasture, S. (2009). Protective effect of Solanum torvum on doxorubicin-induced cardiactoxicity in rats. Pharmacologyonline, 2, 1192–1204.
38.
go back to reference Mohan, M., Kamble, S., Satyanarayana, J., Nageshwar, M., & Reddy, N. (2011). Protective effect of Solanum torvum on doxorubicin-induced hepatotoxicity. International Journal of Drug Development and Research, 3, 131–138. Mohan, M., Kamble, S., Satyanarayana, J., Nageshwar, M., & Reddy, N. (2011). Protective effect of Solanum torvum on doxorubicin-induced hepatotoxicity. International Journal of Drug Development and Research, 3, 131–138.
39.
go back to reference Tkachev, V. O., Menshchikova, E. B., & Zenkov, N. K. (2011). Mechanism of the Nrf2/Keap1/ARE signaling system. Biochemistry (Moscow), 76, 407–422.CrossRef Tkachev, V. O., Menshchikova, E. B., & Zenkov, N. K. (2011). Mechanism of the Nrf2/Keap1/ARE signaling system. Biochemistry (Moscow), 76, 407–422.CrossRef
40.
go back to reference Hayes, J. D., McMahon, M., Chowdhry, S., & Dinkova-Kostova, A. T. (2010). Cancer chemoprevention mechanisms mediated through the Keap1–Nrf2 pathway. Antioxidants and Redox Signaling, 13, 1714–1748.CrossRef Hayes, J. D., McMahon, M., Chowdhry, S., & Dinkova-Kostova, A. T. (2010). Cancer chemoprevention mechanisms mediated through the Keap1–Nrf2 pathway. Antioxidants and Redox Signaling, 13, 1714–1748.CrossRef
41.
go back to reference Ma, K., Zhang, Y., Zhu, D., & Lou, Y. (2009). Protective effect of asiatic acid d-galactosamine/lipopolysaccharide-induced hepatotocixicity in hepatocyte and Kupffer cells co-cultured system via redox regulated leukotrien C4 synthase expression pathways. European Journal of Pharmacology, 603, 98–107.CrossRefPubMed Ma, K., Zhang, Y., Zhu, D., & Lou, Y. (2009). Protective effect of asiatic acid d-galactosamine/lipopolysaccharide-induced hepatotocixicity in hepatocyte and Kupffer cells co-cultured system via redox regulated leukotrien C4 synthase expression pathways. European Journal of Pharmacology, 603, 98–107.CrossRefPubMed
Metadata
Title
Asiatic Acid Ameliorates Doxorubicin-Induced Cardiac and Hepato-Renal Toxicities with Nrf2 Transcriptional Factor Activation in Rats
Authors
Sarika M. Kamble
Chandragouda R. Patil
Publication date
01-04-2018
Publisher
Springer US
Published in
Cardiovascular Toxicology / Issue 2/2018
Print ISSN: 1530-7905
Electronic ISSN: 1559-0259
DOI
https://doi.org/10.1007/s12012-017-9424-0

Other articles of this Issue 2/2018

Cardiovascular Toxicology 2/2018 Go to the issue